asa guidelines for glp 1 drugs Glucagon-Like Peptide-1 Receptor Agonists in Perioperative Care New Year, New Bod? Words
Description
Funding This work was supported by grants from the Chung Shan Medical University Hospital (CSH-2020-C-016)
Collins KH, Herzog W, MacDonald GZ, et al
The study evaluated the 10 mg and 15 mg doses of tirzepatide, which led to an average weight loss of 13.4% and 15.7% from baseline, respectively
Heart Disease and Stroke Statistics2023 Update: A Report From the American Heart Association
With that being said, the risks and benefits for those who use the drugs for weight loss would differ from that for people who are using them for the management of diabetes
